申请人:ONO PHARMACEUTICAL CO., LTD.
公开号:US20150152112A1
公开(公告)日:2015-06-04
The present invention provides compounds of the general formula (I), their salts and N-oxides, and solvates and prodrugs thereof (wherein the characters are as defined in the description). The compounds of the general formula (I) are inhibitors of Factor XIa, so that they are useful in the prevention of and/or therapy for thromboembolic diseases.
本发明提供了一般式(I)的化合物,它们的盐和N-氧化物,以及它们的溶剂化物和前药(其中字符如描述中所定义)。一般式(I)的化合物是因子XIa的抑制剂,因此它们在预防和/或治疗血栓性疾病方面非常有用。